ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2021; 12(23):6948. doi:10.7150/jca.67290 This issue Cite
Retraction
Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway
Citation:
Journal of Cancer . Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer 2021; 12(23):6948. doi:10.7150/jca.67290. https://www.jcancer.org/v12p6948.htm
Other styles
Retracted-article in J Cancer, Volume 10, 6511
This article (IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. Chuan Zhang, Kun Ma, Wu-Yin Li. J Cancer 2019; 10(26):6511-6525) has been retracted due to concerns on multiple image duplications as identified by PubPeer users. The corresponding author has been contacted by the journal, and the authors expressed apology for their negligence and mistakes in this paper.
Published 2021-10-8
Citation styles
APA
Journal of Cancer (2021). Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. Journal of Cancer, 12(23), 6948. https://doi.org/10.7150/jca.67290.
ACS
Journal of Cancer Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J. Cancer 2021, 12 (23), 6948. DOI: 10.7150/jca.67290.
NLM
Journal of Cancer . Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer 2021; 12(23):6948. doi:10.7150/jca.67290. https://www.jcancer.org/v12p6948.htm
CSE
Journal of Cancer . 2021. Retraction: IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer. 12(23):6948.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
